Advances in Cancer Research in Idaho

Organized by the Idaho Cancer Research Association

28^th March, 2008, College of Western Idaho, Boise

Chair- Alok Bhushan, Ph.D.                         Co-Chair-James C K Lai, Ph.D.

9:15AM –“Breast cancer metastasis to bone”

Cheryl Jorcyk, Ph.D. Department of Biology, Boise State University, Boise

9:45 AM- “Idaho’s Hit List: How Can We Make the Most Impact on Cancer in Idaho”

Patti Moran, MHS, Idaho Department of Health and Welfare

10:15 AM – Inhibitors of Glycolytic Enzymes: Induction of Cancer Cell Death & Alteration in Cell Signaling

James C. K. Lai, Ph.D. Department of Biomedical and Pharmaceutical Sciences, Idaho State University

10:45 AM – Inhibition of Carbonyl Reductase as a Means to Improve Anthracycline Chemotherapy

Henry A. Charlier, Jr., Ph.D. Department of Chemistry and Biochemistry, Boise State University, Boise

11:15 AM- "Evaluation of DNA Cross-Linking by Aziridinomitosenes"

Don Warner, Ph.D. Department of Chemistry and Biochemistry, Boise State University, Boise

11:45 AM- An isoflavone Biochanin-A, modulates growth promoting, survival and antioxidant pathways in HER positive breast cancer cells

Vikas Sehdev, Doctoral student Department of Dental Hygiene, Idaho State University

12:15 PM – Lunch

2:00 PM-“Antifolate Resistance: Role of a novel protein”

Alok Bhushan, Ph.D. Department of Biomedical and Pharmaceutical Sciences, Idaho State University

2:30 PM-“Characterization of the novel methotrexate resistance protein”

Christopher Daniels, Ph.D. Department of Biomedical and Pharmaceutical Sciences, Idaho State University

3:00 PM- “Effects of isoflavones and glycolytic enzyme inhibitors on signaling pathways in oral squamous cell carcinoma”

Tara Johnson, Ph.D. Department of Dental Hygiene, Idaho State University

3:30 PM- 4,4¢-Disubstituted-2,2¢-bipyridine Pt(II) Complexes: Cisplatin Analogues of Increased Cytotoxicity

Byron Bennett, Ph.D. Department of Chemistry, Idaho State University